Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...
Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...
Individual mammalian cells contain billions of protein molecules, which must be synthesized, deployed, and removed with ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback